Lacey J Padrón

Sotigalimab and/or nivolumab with chemotherapy in first-line metastatic pancreatic cancer: clinical and immunologic analyses from the randomized phase 2 PRINCE trial

Christopher R. Cabanski, Vanessa M. Hubbard-Lucey, E. Wherry, 2022, Nature Medicine.

1256 Relationships between irAEs and checkpoint inhibitor response in RADIOHEAD: a large prospective pan-tumor cohort of standard-of-care patients with clinical annotation, molecular and immune profiling

Diane Da Silva, C. Spencer, Z. Quandt, 2022, Regular and Young Investigator Award Abstracts.

Immunologic signatures of response and resistance to nivolumab with ipilimumab in advanced metastatic cancer.

F. Hodi, S. Kummar, D. Khalil, 2024, The Journal of experimental medicine.